Viral vectors dominate gene therapy, with lentivirus, adenovirus, and AAV being key players, each with unique advantages and limitations. Non-viral vectors, such as lipid nanoparticles and GalNAc, ...
Proceedings of the National Academy of Sciences of the United States of America, Vol. 93, No. 21 (Oct. 15, 1996), pp. 11307-11312 (6 pages) Herpes simplex virus vectors are being developed for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results